Obesity Inhibits Angiogenesis Through TWIST1-SLIT2 Signaling

Tendai Hunyenyiwa1,2, Kathryn Hendee1, Kienna Matus1

  • 1Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, United States.

Insights

Obesity impairs blood vessel formation in adipose tissue by reducing TWIST1 and SLIT2 signaling in endothelial cells (ECs). Restoring TWIST1 levels can improve angiogenesis in obese adipose tissue.

Area of Science:

  • Endocrinology
  • Vascular Biology
  • Cell Biology

Background:

  • Angiogenesis is crucial for adipose tissue function, but it is impaired in obese individuals.
  • The precise mechanisms inhibiting angiogenesis in obese adipose tissue remain unclear.
  • TWIST1 is a transcription factor known to regulate angiogenesis and vascular function.

Purpose of the Study:

  • To investigate the role of TWIST1-SLIT2 signaling in the inhibition of angiogenesis in obese human adipose tissue.
  • To elucidate the molecular mechanisms underlying impaired vascularization in obesity.

Main Methods:

  • Isolation and culture of endothelial cells (ECs) from lean and obese human adipose tissues.
  • Manipulation of TWIST1 expression (knockdown and overexpression) in ECs.
  • Assessment of SLIT2 expression, EC DNA synthesis, and cell migration.
  • In vivo assessment of blood vessel formation using subcutaneous implantation in mice.

Main Results:

  • TWIST1 and SLIT2 levels are significantly lower in ECs from obese adipose tissue compared to lean controls.
  • TWIST1 regulates SLIT2 expression; TWIST1 knockdown reduces SLIT2, while TWIST1 overexpression restores it.
  • Obese ECs exhibit reduced DNA synthesis and migration, which are rescued by TWIST1 overexpression.
  • In vivo, obese ECs impair blood vessel formation, an effect reversed by SLIT2 or TWIST1-overexpressing ECs.

Conclusions:

  • Obesity impairs adipose tissue angiogenesis via a mechanism involving reduced TWIST1-SLIT2 signaling in endothelial cells.
  • TWIST1-SLIT2 pathway represents a potential therapeutic target for improving adipose tissue vascularization in obesity.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.2K